OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Blackburn Statement on House Passage of Bipartisan Drug Safety Legislation

Statement

Date: Sept. 28, 2013
Location: Washington, DC
Issues: Business and Consumers Health and Health Care

Congressman Marsha Blackburn (R-TN) today issued the following statement on House passage of H.R. 3204, the Drug Quality and Security Act. This bipartisan piece of legislation would help improve drug safety and help prevent future public health crisis like the 2012 deadly meningitis outbreak that impacted so many in Tennessee.

"This past year, a meningitis outbreak claimed 16 lives in Tennessee and 64 lives across the nation, and plagued hundreds of Americans. The cases stemmed from contaminated compounded drugs manufactured in some cases without the consent of the FDA. Traditional compounding is critical for patient needs and this legislation ensures millions of our most vulnerable relatives, friends, and neighbors continue to have safe access to essential and lifesaving medication. As a result of our investigation at Energy and Commerce, the bipartisan passage of H.R. 3204 will ensure necessary steps are identified to prevent a tragic outbreak from happening again.


Source
arrow_upward